Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/25296
DC FieldValueLanguage
dc.contributor.authorMihajlovska Dzulijanaen_US
dc.contributor.authorSmokovski Ivicaen_US
dc.contributor.authorKocinski Goranen_US
dc.contributor.authorAntova, Emilijaen_US
dc.contributor.authorPetkovska, Lidijaen_US
dc.contributor.authorBosevski, Marijanen_US
dc.date.accessioned2022-12-28T12:41:16Z-
dc.date.available2022-12-28T12:41:16Z-
dc.date.issued2019-10-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/25296-
dc.description03-06 October 2019, Ohrid, North Macedoniaen_US
dc.language.isoenen_US
dc.publisherMacedonian Society of Cardiologyen_US
dc.titleNational prevalence of heart failure in type 2 diabetes patients derived from the National eHealth System and their access to treatment with SGLT2 inhibitors or GLP-1 Receptor Agonistsen_US
dc.typeProceeding articleen_US
dc.relation.conferenceSixth Congress of the Macedonian Society of Cardiologyen_US
item.grantfulltextopen-
item.fulltextWith Fulltext-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Conference papers
Files in This Item:
File Description SizeFormat 
K. kardio 2019, K8.jpg3.33 MBJPEGThumbnail
View/Open
Show simple item record

Page view(s)

48
checked on May 13, 2024

Download(s)

4
checked on May 13, 2024

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.